HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Evaluation of a selective prostaglandin E receptor EP1 antagonist for potential properties in colon carcinogenesis.

AbstractBACKGROUND:
Cyclooxygenases (COXs) and prostanoids play pivotal roles in colon carcinogenesis. This study was designed to determine the chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP1 antagonist, on the development of azoxymethane (AOM)-induced colonic aberrant crypt foci (ACF) in male F344 rats and to compare its potential with that of nimesulide, a well-documented selective COX-2 inhibitor.
MATERIALS AND METHODS:
Five-week-old male F344 rats received s.c. injections of AOM (15 mg/kg body weight) or the saline vehicle once weekly for two weeks and were fed the control diet (AIN-76A) or the experimental diets containing 400 or 800 ppm of ONO-8711 or 400 ppm nimesulide for 5 weeks.
RESULTS:
Administration of ONO-8711 at 800 ppm significantly reduced the total number of ACF/colon and 5-bromodeoxyuridine (BrdUrd) labeling index as compared to the control diet group (by 31% and 66%, respectively). As expected, dietary administration of nimesulide also suppressed the development of ACF and BrdUrd labeling index in the colon, by about 39% and 54%, respectively.
CONCLUSION:
Our finding that ONO-8711 significantly suppresses colonic ACF formation and cell proliferation strengthens the hypothesis that the selective prostaglandin E receptor EP1 antagonists possesses chemopreventive activity against colon cancer development.
AuthorsT Kawamori, N Uchiya, T Kitamura, S Ohuchida, H Yamamoto, T Maruyama, T Sugimura, K Wakabayashi
JournalAnticancer research (Anticancer Res) 2001 Nov-Dec Vol. 21 Issue 6A Pg. 3865-9 ISSN: 0250-7005 [Print] Greece
PMID11911260 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticarcinogenic Agents
  • Bicyclo Compounds
  • Caproates
  • Carcinogens
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Isoenzymes
  • ONO 8711
  • Receptors, Prostaglandin E
  • Receptors, Prostaglandin E, EP1 Subtype
  • Sulfonamides
  • Cyclooxygenase 2
  • Prostaglandin-Endoperoxide Synthases
  • Azoxymethane
  • nimesulide
Topics
  • Animals
  • Anticarcinogenic Agents (pharmacology)
  • Azoxymethane (antagonists & inhibitors, toxicity)
  • Bicyclo Compounds (pharmacology)
  • Caproates (pharmacology)
  • Carcinogens (antagonists & inhibitors, toxicity)
  • Cell Division (drug effects)
  • Colonic Neoplasms (chemically induced, pathology, prevention & control)
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors (pharmacology)
  • DNA Fragmentation (drug effects)
  • Isoenzymes (antagonists & inhibitors)
  • Male
  • Precancerous Conditions (chemically induced, pathology, prevention & control)
  • Prostaglandin-Endoperoxide Synthases
  • Rats
  • Rats, Inbred F344
  • Receptors, Prostaglandin E (antagonists & inhibitors)
  • Receptors, Prostaglandin E, EP1 Subtype
  • Sulfonamides (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: